OSU 6162 clinical trials
Also written OSU 6162.
How each study uses OSU 6162 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the OSU 6162 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2017 | 2 |
| 2021 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
Göteborg University (2) · Arvid Carlsson Research AB (1) · Oslo University Hospital (1)
Studies
Open first, then newest update. How each study uses OSU 6162 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- OSU6162 as add-on in SSRI/SNRI-resistant DepressionRecruitingPhase 2Göteborg UniversityNCT05641623Written as OSU6162
- OSU6162 in Bipolar Depression (OBID)RecruitingPhase 2Göteborg UniversityNCT05296356Written as OSU6162
- Study Evaluating Efficacy and Safety of OSU6162 in the Treatment of Residual Symptoms After StrokeCompletedPhase 2Arvid Carlsson Research ABNCT04127669Written as OSU 6162
- Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid HemorrhageCompletedPhase 2Oslo University HospitalNCT03209830Written as OSU 6162
Codes
What other systems call OSU 6162 · ClinicalTrials.gg INT004034
- MeSH (NLM) C109513OSU 6162Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0D21EQAQQAOSU-6162Confirmed NLM, Wikidata
- Wikidata Q6593699OSU-6162Confirmed NLM, Wikidata
- DrugBank DB19178One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C109513 | OSU 6162 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0D21EQAQQA | OSU-6162 | Confirmed NLM, Wikidata |
| Wikidata | Q6593699 | OSU-6162 | Confirmed NLM, Wikidata |
| DrugBank | DB19178 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.